TY - JOUR
T1 - Neuroendocrine Tumors
T2 - Current Recommendations for Diagnosis and Surgical Management
AU - Joseph, Saju
AU - Wang, Yi Zarn
AU - Boudreaux, J. Philip
AU - Anthony, Lowell B.
AU - Campeau, Richard
AU - Raines, Daniel
AU - O'Dorisio, Thomas
AU - Go, Vay Liang
AU - Vinik, Aaron I.
AU - Cundiff, Jason
AU - Woltering, Eugene A.
PY - 2011/3
Y1 - 2011/3
N2 - Neuroendocrine tumors (NETs) are rare neoplasms found in diverse locations within the body. These tumors are commonly classified by the primary tumor's location, further subclassified by their differentiation, and finally segregated by their ability to hypersecrete peptides or amines. A number of groups have summarized their recommendations for diagnosis and therapy; however, the rarity of these lesions makes prospective randomized multiinstitutional trials difficult. Thus, these "consensus statements" often remain opinion-based. The authors have collaboratively developed a consensus on the current diagnostic work-up necessary for patients with NETs to help clinicians with this confusing field and followed this with some of the more advanced surgical techniques and considerations that are currently only available in specialty centers to show the evolving management of NETs.
AB - Neuroendocrine tumors (NETs) are rare neoplasms found in diverse locations within the body. These tumors are commonly classified by the primary tumor's location, further subclassified by their differentiation, and finally segregated by their ability to hypersecrete peptides or amines. A number of groups have summarized their recommendations for diagnosis and therapy; however, the rarity of these lesions makes prospective randomized multiinstitutional trials difficult. Thus, these "consensus statements" often remain opinion-based. The authors have collaboratively developed a consensus on the current diagnostic work-up necessary for patients with NETs to help clinicians with this confusing field and followed this with some of the more advanced surgical techniques and considerations that are currently only available in specialty centers to show the evolving management of NETs.
KW - Biochemical markers
KW - Chemotherapy
KW - Foregut
KW - Hindgut
KW - Imaging
KW - Midgut
KW - Neuroendocrine tumors
KW - Radiation therapy
KW - Surgery
KW - Tumor markers
UR - http://www.scopus.com/inward/record.url?scp=79951734388&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79951734388&partnerID=8YFLogxK
U2 - 10.1016/j.ecl.2010.08.004
DO - 10.1016/j.ecl.2010.08.004
M3 - Review article
C2 - 21349420
AN - SCOPUS:79951734388
SN - 0889-8529
VL - 40
SP - 205
EP - 231
JO - Endocrinology and Metabolism Clinics of North America
JF - Endocrinology and Metabolism Clinics of North America
IS - 1
ER -